MIM
IMDX

MetLife Investment Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

MetLife Investment Management’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,448
Closed -$166K – 2578
2021
Q2 		$166K Buy
1,448
+1,361
+1,564% +$156K ﹤0.01% 2268
2021
Q1 		$9.03K Buy
+87
New +$9.03K ﹤0.01% 2309